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Glioblastoma (GBM) is the most common and deadly primary brain tumor, 
accounting for over 10,000 new cancer diagnoses in the United States each year. 
The poor prognosis for GBM patients necessitates novel biological treatments. 
One such approach is the use of oncolytic herpes simplex virus 1 (oHSV). Like 
many novel treatments, oHSV therapy causes side effects that are not yet well 
understood. Our lab has demonstrated that oHSV treatment increases the 
vascularity of brain tumors. The goal of this study is to determine the mechanism 
by which oHSV treatment increases the vascularity of brain tumors. We have 
determined that the hypoxia inducible factor-1 alpha (HIF1α) is activated in cells 
infected with oHSV, even in normal oxygen conditions. HIF1α is a transcription 
factor which activates a variety of genes in response to a lack of oxygen. We 
believe that HIF1α activation may be responsible for the increased vascularity of 
oHSV treated brain tumors. A screen of targetscan.org for herpes simplex virus 1 
(HSV-1) miRNAs and their predicted target genes revealed multiple miRNAs  
predicted to target a protein called, factor inhibiting HIF1α (FIH). This protein 
functionally inhibits HIF1α activation by preventing the binding of HIF1α to DNA. 
We hypothesized that FIH would be negatively regulated in GBM cells infected 
with oHSV, thus allowing HIF1α activation. In this study, we demonstrate that 
HSV-1 expresses two miRNA molecules, which target and down regulate FIH. 
Transfection of miRNA inhibitors (antagomirs) was able to successfully abrogate 
the virus' ability to downregulate FIH as demonstrated by quantitative PCR and 
western blot. Moreover, transfection of HSV-1 miRNA mimics in the absence of 
virus was able to downregulate FIH protein levels (western blot) and activate the 
expression of a variety of HIF1α driven genes, including VEGF and CCN1 
(quantitative PCR). Our future aim is to determine if HSV-1 encodes for miRNA 
capable of binding to the 3' untranslated region (3' UTR) of FIH. For this study we 
will employ an FIH-3' UTR luciferase reporter vector. This experiment will 
demonstrate if the miRNA expressed by oHSV directly binds to the 3' UTR of FIH, 
thus inhibiting FIH gene expression, and activating HIF1α. 
Abstract oHSV infection activates the hypoxia response element promoter  
Down regulation of FIH is mediated by 
miRNA expressed by oHSV HSV miRNA Activates NF-kB 
Oncolytic virotherapy increases tumor 
vascularity and vascular leakiness 
oHSV induces down regulation of factor 
inhibiting HIF1α (FIH) 
 Figure 1. oHSV increases tumor vascularity. A) Magnetic resonance imaging of tumor 
vasculature in live rats before and after injection of ultra-small particles of iron oxide 
(USPIO). Three days after oncolytic virus (OV) or phosphate-buffered saline (PBS) 
treatment, rats (n = 3 per group) were scanned on an ultra high-field high-resolution 8.0-T 
magnetic resonance imager before and after USPIO was administrated through a femoral 
vein catheter. Subtracted images (after USPIO minus before USPIO) of a tumor from a 
PBS-treated rat (A) 15 minutes and (B) 30 minutes after USPIO administration. 
Subtracted images (after USPIO minus before USPIO) of a tumor from an OV-treated rat 
(C) 15 minutes and (D) 30 minutes after USPIO administration. E) Quantification of 
percent loss in signal intensity compared with the contralateral normal hemisphere in OV-
treated rats at the indicated times after USPIO administration.  
Conclusions & Future Directions 
Figure 4. oHSV infection induces down regulation of factor-inhibiting HIF1α (FIH). 
A) U251T3 glioma cells were infected with increasing concentrations of oHSV 
(34.5ENVE or rHSVQ). Protein was collected and tested by western blot analysis for 
levels of FIH, HIF1α, and GAPDH  (loading control). Following infection, levels of both 
FIH and HIF1α protein decreased. B) To analyze if the down-regulation of FIH was 
specific to herpes virus, LN229 cells were infected with wild type HSV-1, adenovirus 
(ad), vesicular stomatitis virus (VSV), and newcastle disease virus (NDV). FIH protein 
levels only decreased following infection with wtHSV, indicating that negative regulation 
of FIH is specific to HSV infection as opposed to a general cellular response to viral 
infection. 
Inhibition of HSV miRNA rescues FIH   
down regulation 
Figure 7. HSV miRNA activates NF-kB A) LN229 cells were transfected with a 
luciferase reporter for the NF-kB response element (NRE) and were also 
transfected with PGL3 vector or PGL3 with dominant negative IkBa (constitutively 
active). Following treatment with HSV miRNA-H16 mimic or negative control 
(NC), the cells transfected with NRE reporter revealed activation of NF-kB 
transcriptional activity by HSV miRNA-H16.  B) LN229 cells were treated with 
HSV miRNA-H16 mimic or negative control for 24 hours, then protein from 
nuclear and cytosolic fractions was collected. Cells treated with miRNA-H16 were 
positive for nuclear translocation of the p65 fragment of NF-kB. C) LN229 cells 
were again treated with HSV miRNA mimics for 24 hours, and protein was 
collected from whole cell lysates. Transfection of HSV miRNA-H16 mimic 
induced phosphorylation of IkBa kinase (p-IKKa/b), phosphorylation of IkBa, and 
subsequent degredation of IkBa. These results suggest that HSV miRNA-H16 
induces the NF-kB  pathway by causing the phosphorylation of IKK. 
Conclusions 
1)  Treatment with oHSV induces activation of the hypoxia response 
element promoter, and this may be responsible for the increased 
angiogenesis following oHSV therapy of brain tumors. 
2)  HSV and oHSV express multiple miRNAs capable of targeting and down 
regulating FIH, a protein that inhibits the transcriptonal activty of HIF1α. 
To our knowledge, this is the first example of a miRNA molecule 
expressed by HSV1 that is capable of altering human gene expression. 
3)  The miRNAs expressed by oHSV are capable of activating the NF-kB 
pathway. 
A. 
Figure 5. HSV expresses miRNA capable of targeting and down regulating FIH. 
A) U251T3 cells were infected with wild type HSV-1 (WT) or oncolytic HSV (ENVE) 
and miRNA expression was compared to that of uninfected cells after 24 hours.  
Human miRNA-31 and human miRNA-182 were both found to be slightly induced 
upon viral expression, and HSV1 miRNA-h6 and HSV1 miRNA-h16  were detected at 
very high levels after infection. Both HSV miRNA h6 and h16 are were predicted to 
target the 3’ UTR of  FIH. B) U251T3 cells were transfected with miRNA 
overexpression vectors encoding  non-targeting control miRNA (NC), HSV miRNA-
h16, and HSV miRNA-h6. 24 hours following transfection protein was collected and 
analyzed by western blot for FIH and GAPDH (housekeeping gene). Overexpression 
of both HSV miRNA caused negative regulation of FIH protein levels relative to non-
targeting RNA. 
B.  A.  
 Figure 2. oHSV increases vascular permeability. Seven days after D74/HveC glioma 
cell implantation, rats with intracerebral brain tumors were treated with OV or phosphate-
buffered saline (PBS) as a control by direct intracerebral injection. Three days after OV or 
PBS treatment, the rats were injected with Texas red–conjugated tomato lectin via the tail 
vein 5 minutes before they were killed (n = 6 rats per group). The brains were harvested 
and analyzed by immunofluorescence microscopy for changes in the tumor 
vasculature. A) Immunofluorescence images of brain vasculature. Shown are 
representative images of contralateral normal brain (left panels) and tumor area from 
control-treated (middle panels) and OV-treated (right panels) rats at ×20 (top row) and ×4 
(bottom row) magnification.  B) Quantification of the leaked fluorescent dye in normal 
brain, PBS-treated tumor tissue, and OV-infected tumor tissue relative to the level in 
contralateral normal untreated brain in each slice.  
Figures 1 & 2 previously published Kurozumi et al. 
Figure 3. Treatment of oHSV activates the HRE promoter. A) LN229-V6R 
glioma cells were stably transfected with an HRE-luciferase/LacZ reporter vector 
and infected with increasing concentrations of oncolytic virus. oHSV treatment 
induced HRE dependent luciferase expression in a dose dependent manner. B) 
LN229-V6R were transfected with the reporter vector and infected with oHSV in 
normoxia. LacZ staining revealed increased HRE promoter activity following oHSV 
infection.  C) oHSV followed by LacZ staining was repeated as in (B) but cells were 
cultured and infected in hypoxia. LacZ staining demonstrates no significant 
increase in HRE promoter activity in hypoxia following oHSV infection. D) LN229-
V6R cells were infected with increasing concentrations of oHSV in normoxia. RNA 
was collected used to synthesize cDNA, and analyzed by real-time PCR for VEGF 
expression. Relative VEGF expression increased following oHSV infection, 
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Figure 6. HSV expresses miRNA capable of targeting and down regulating FIH. 
A) U251T3 glioma cells were transfected with antagomirs specific to HSV miRNA-
h6,HSV miRNA-h16, non-targeting control RNA (NC), or were not transfected at all 
(untreated). Cells were then infected with oHSV or left uninfected, and FIH protein 
levels were analyzed by western blot. While oHSV infection down regulated FIH 
levels in untreated cells and control RNA-transfected cells, transfection of antagomirs 
which specifically inhibited HSV miRNA-H16 and HSV miRNA-h6 rescued FIH down 
regulation. B) LN229 glioma cells were transfected with antagomirs and infected with 
oHSV as in (A). Antagomir treatment rescued FIH down regulation in a similar 
manner, confirming the effect in another cell line. C) U251T3 cells were infected with 
wild type HSV1, oHSV, or left uninfected, and RNA was collected after 24 hours and 
converted to cDNA for real time PCR analysis using primers for FIH and GAPDH 
(housekeeping gene). FIH expression relative to GAPDH did not change following 
HSV infection. 























1)  Demonstrate that overexpression of miRNAs is capable of activating the 
HRE promoter using the HRE-Luc/LacZ reporter vector. 
2)  Use antagomirs to demonstrate rescue of HRE activation following 
oHSV infection. 
3)  Develop an oncolytic virus that does not express HSV miRNA-H16 and 
HSV miRNA-H6. This next generation virus would have the potential to 
fully replicate in cancer cells without creating the negative side effect of 
increased tumor vascularity 
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